BEBT-109 is a potent selective inhibitor of pan-mutant EGFR with enhanced pharmacokinetic properties, suitable for research on various mutant-EGFR-driven non-small cell lung cancer (NSCLC) [1].
Molecular Weight:
516.59
CAS Number:
[2050906-40-4]
Formula:
C27H32N8O3
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted